Intalere Members Benefit through New Agreement with AngioDynamics
St. Louis (March 23, 2021) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new agreement for medical devices from AngioDynamics, Inc.
Through this agreement, Intalere members will receive negotiated pricing on the BioFlo PICC and Smart Port +, which are the first of each respective category to utilize Endexo Technology, providing a catheter more resistant to the accumulation of blood components (platelets and thrombus). Also available to members is the BioFlo Midline Catheter, which provides a cost-effective alternative to multiple IV site rotations for patients who need short-term venous access.
This contract is currently effective through January 30, 2024.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.